Efavirenz-rifampicin interaction: therapeutic drug monitoring to efavirenz dosage optimization in HIV/TBC patients.
Cabrera
Salvador E
SE
Cordero
Miguel
M
Iglesias
Alicia
A
Valverde
María P
MP
Domínguez-Gil
Alfonso
A
García
María J
MJ
D000328:Adult; D000480:Alkynes; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D048588:Benzoxazines / Q000627:therapeutic use*; D003521:Cyclopropanes; D004347:Drug Interactions; D016903:Drug Monitoring; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy*
D000480:Alkynes; D000904:Antibiotics, Antitubercular; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz; D012293:Rifampin